Qiong (Karrie) Wang
About Qiong (Karrie) Wang
Qiong (Karrie) Wang is the Vice President of Biostatistics at Marker Therapeutics, Inc., where she has worked since 2021. She has extensive experience in biostatistics, having held various positions at GSK and other organizations over her career.
Current Role at Marker Therapeutics
Qiong (Karrie) Wang serves as the Vice President of Biostatistics at Marker Therapeutics, Inc. since 2021. In this role, she oversees the biostatistical aspects of clinical trials and contributes to the strategic planning and execution of statistical analyses. Her leadership in biostatistics supports the company’s mission in advancing innovative therapies.
Previous Experience at Cornerstone Pharmaceuticals
Before joining Marker Therapeutics, Wang worked at Cornerstone Pharmaceuticals as Senior Director of Statistics for a period of five months in 2021. In this position, she was responsible for leading statistical methodologies and ensuring robust statistical support for clinical development projects.
Career Background at GSK
Wang has an extensive background at GSK, where she held multiple roles over several years. She served as Principal Statistician from 2008 to 2011, Director of Clinical Statistics from 2017 to 2021, and Manager of Statistics from 2011 to 2015. Her work involved designing and analyzing clinical trials, contributing to regulatory submissions, and collaborating with cross-functional teams.
Education and Expertise in Statistics
Wang earned her Doctor of Philosophy (Ph.D.) in Statistics from North Carolina State University (NCSU), completing her studies from 2002 to 2005. Her academic background provides a strong foundation for her expertise in biostatistics, enabling her to apply advanced statistical techniques in clinical research.
Early Career at St. Jude Medical and MedFocus
Wang began her career as a Biostatistician at St. Jude Medical for five months in 2005-2006, where she gained initial experience in the field. She later worked at MedFocus as a Biostatistician from 2006 to 2007, further developing her skills in statistical analysis and clinical data evaluation.